SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 30 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $103,000 | -8.8% | 77,334 | 0.0% | 0.00% | – |
| Q2 2020 | $113,000 | +59.2% | 77,334 | 0.0% | 0.00% | – |
| Q1 2020 | $71,000 | -70.9% | 77,334 | -50.0% | 0.00% | – |
| Q4 2019 | $244,000 | -9.6% | 154,668 | +100.0% | 0.00% | – |
| Q3 2019 | $270,000 | -5.6% | 77,334 | -0.4% | 0.00% | – |
| Q2 2019 | $286,000 | -77.8% | 77,682 | -36.7% | 0.00% | – |
| Q1 2019 | $1,288,000 | -47.0% | 122,790 | -47.5% | 0.00% | – |
| Q4 2018 | $2,428,000 | +87.6% | 233,722 | +117.5% | 0.00% | – |
| Q3 2018 | $1,294,000 | +38.8% | 107,463 | +36.5% | 0.00% | – |
| Q2 2018 | $932,000 | +21.2% | 78,721 | +57.2% | 0.00% | – |
| Q1 2018 | $769,000 | +14.3% | 50,065 | 0.0% | 0.00% | – |
| Q4 2017 | $673,000 | -20.2% | 50,065 | 0.0% | 0.00% | – |
| Q3 2017 | $843,000 | +208.8% | 50,065 | +148.1% | 0.00% | – |
| Q2 2017 | $273,000 | – | 20,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,301,701 | $4,803,000 | 0.52% |
| SECTORAL ASSET MANAGEMENT INC | 276,656 | $1,021,000 | 0.12% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 277,263 | $1,023,000 | 0.11% |
| CAXTON CORP | 23,821 | $88,000 | 0.10% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $1,522,000 | 0.08% |
| Private Capital Advisors, Inc. | 52,335 | $193,000 | 0.06% |
| Pegasus Asset Management, Inc. | 18,750 | $69,000 | 0.05% |
| Hikari Power Ltd | 61,336 | $226,000 | 0.02% |
| Lee Financial Co | 18,750 | $69,000 | 0.02% |
| Baker Brothers Advisors | 613,144 | $2,263,000 | 0.02% |